Related references
Note: Only part of the references are listed.In vivo increase in thrombin generation by four-factor prothrombin complex concentrate in apixaban-treated healthy volunteers
Y. W. Cheung et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
Reversal of oral factor Xa inhibitors by prothrombin complex concentrates: a re-appraisal
W. H. Dzik
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
Multimodal assessment of non-specific hemostatic agents for apixaban reversal
A. -C. Martin et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
Correlation of Coagulation Markers and 4F-PCC-Mediated Reversal of Rivaroxaban in a Rabbit Model of Acute Bleeding
Eva Herzog et al.
THROMBOSIS RESEARCH (2015)
Administration of 4-Factor Prothrombin Complex Concentrate as an Antidote for Intracranial Bleeding in Patients Taking Direct Factor Xa Inhibitors
Ramesh Grandhi et al.
WORLD NEUROSURGERY (2015)
Evaluation of recombinant activated factor VII, prothrombin complex concentrate, and fibrinogen concentrate to reverse apixaban in a rabbit model of bleeding and thrombosis
Anne-Celine Martin et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Reversal of novel oral anticoagulants in patients with major bleeding
Deborah M. Siegal et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2013)
Reversal of Apixaban Induced Alterations in Hemostasis by Different Coagulation Factor Concentrates: Significance of Studies In Vitro with Circulating Human Blood
Gines Escolar et al.
PLOS ONE (2013)
The new oral anti-coagulants and the phase 3 clinical trials - a systematic review of the literature
Faryal Tahir et al.
THROMBOSIS JOURNAL (2013)
Evidence-Based Management of Anticoagulant Therapy Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Anne Holbrook et al.
CHEST (2012)
New anticoagulants: A concise review
Lisa M. Baumann Kreuziger et al.
JOURNAL OF TRAUMA AND ACUTE CARE SURGERY (2012)
Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex Concentrate A Randomized, Placebo-Controlled, Crossover Study in Healthy Subjects
Elise S. Eerenberg et al.
CIRCULATION (2011)
Apixaban for Reduction In Stroke and Other ThromboemboLic Events in Atrial Fibrillation (ARISTOTLE) trial: Design and rationale
Renato D. Lopes et al.
AMERICAN HEART JOURNAL (2010)
Oral anticoagulants: Mechanism of action, clinical effectiveness, and optimal therapeutic range
J Hirsh et al.
CHEST (2001)
Share Paper
